Paper39338348
Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application.
Fedotcheva TA and 3 others. Pharmaceuticals (Basel), 2024. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application. Papers, record 39338348. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39338348
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Dehydroepiandrosterone and Its Metabolite 5-Androstenediol: New Therapeutic Targets and Possibilities for Clinical Application.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 24-24-00280 | Russian Science Foundation | PubMed |
Source PubMed
References126
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19752325 | Dehydroepiandrosterone reverses systemic vascular remodeling through the inhibition of the Akt/GSK3-{beta}/NFAT axis. | Circulation | 2009 | https://conductscience.org/library/papers/19752325 | PubMed |
| 2 | 20691987 | Dehydroepiandrosterone during sepsis: does the timing of administration influence the effectiveness. | J Surg Res | 2010 | https://conductscience.org/library/papers/20691987 | PubMed |
| 3 | 26291918 | Serum levels of sex steroids and metabolites following 12 weeks of intravaginal 0.50% DHEA administration. | J Steroid Biochem Mol Biol | 2015 | https://conductscience.org/library/papers/26291918 | PubMed |
| 4 | 30326923 | Central intracrine DHEA synthesis in ageing-related neuroinflammation and neurodegeneration: therapeutic potential? | J Neuroinflammation | 2018 | https://conductscience.org/library/papers/30326923 | PubMed |
| 5 | 38007170 | Neuroactive steroids and Parkinson's disease: Review of human and animal studies. | Neurosci Biobehav Rev | 2024 | https://conductscience.org/library/papers/38007170 | PubMed |
| 6 | 22032408 | Dehydroepiandrosterone (DHEA)--a precursor steroid or an active hormone in human physiology. | J Sex Med | 2011 | https://conductscience.org/library/papers/22032408 | PubMed |
| 7 | 21541365 | Neurosteroid dehydroepiandrosterone interacts with nerve growth factor (NGF) receptors, preventing neuronal apoptosis. | PLoS Biol | 2011 | https://conductscience.org/library/papers/21541365 | PubMed |
| 8 | 16407456 | G protein-associated, specific membrane binding sites mediate the neuroprotective effect of dehydroepiandrosterone. | FASEB J | 2006 | https://conductscience.org/library/papers/16407456 | PubMed |
| 9 | 35582271 | Components of the human-specific, p53-mediated "kill switch" tumor suppression mechanism are usurped by human tumors, creating the possibility of therapeutic exploitation. | Cancer Drug Resist | 2019 | https://conductscience.org/library/papers/35582271 | PubMed |
| 10 | 35056103 | The Utilization of Dehydroepiandrosterone as a Sexual Hormone Precursor in Premenopausal and Postmenopausal Women: An Overview. | Pharmaceuticals (Basel) | 2021 | https://conductscience.org/library/papers/35056103 | PubMed |
| 11 | 9876338 | The effect of six months treatment with a 100 mg daily dose of dehydroepiandrosterone (DHEA) on circulating sex steroids, body composition and muscle strength in age-advanced men and women. | Clin Endocrinol (Oxf) | 1998 | https://conductscience.org/library/papers/9876338 | PubMed |
| 12 | 23123738 | DHEA metabolites activate estrogen receptors alpha and beta. | Steroids | 2013 | https://conductscience.org/library/papers/23123738 | PubMed |
| 13 | 19836365 | Pharmacokinetic and tissue distribution study of [14C]fluasterone in male Beagle dogs following intravenous, oral and subcutaneous dosing routes. | Chem Biol Interact | 2010 | https://conductscience.org/library/papers/19836365 | PubMed |
| 14 | 15832488 | Effects of dehydroepiandrosterone on bone mineral density: what implications for therapy? | Treat Endocrinol | 2002 | https://conductscience.org/library/papers/15832488 | PubMed |
| 15 | 30029723 | Dehydroepiandrosterone Research: Past, Current, and Future. | Vitam Horm | 2018 | https://conductscience.org/library/papers/30029723 | PubMed |
| 16 | 10480450 | Correlation between the administered dose of DHEA and serum levels of DHEA and DHEA-S in human volunteers: analysis of published data. | Clin Biochem | 1999 | https://conductscience.org/library/papers/10480450 | PubMed |
| 17 | 30959020 | The novel dehydroepiandrosterone (DHEA) derivative BNN27 counteracts behavioural deficits induced by the NMDA receptor antagonist ketamine in rats. | Neuropharmacology | 2019 | https://conductscience.org/library/papers/30959020 | PubMed |
| 18 | 11194714 | DHEA: A forgettable steroid? | J Endocrinol Invest | 2000 | https://conductscience.org/library/papers/11194714 | PubMed |
| 19 | 28082899 | BNN27, a 17-Spiroepoxy Steroid Derivative, Interacts With and Activates p75 Neurotrophin Receptor, Rescuing Cerebellar Granule Neurons from Apoptosis. | Front Pharmacol | 2016 | https://conductscience.org/library/papers/28082899 | PubMed |
| 20 | 34089761 | On the role of sex steroids in biological functions by classical and non-classical pathways. An update. | Front Neuroendocrinol | 2021 | https://conductscience.org/library/papers/34089761 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653433 | Sarcopenia and Frailty in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): The Impact of Steroid Hormones. | Int J Mol Sci | 2026 | https://conductscience.org/library/papers/42653433 | PubMed |
| 42177729 | Exploratory gut microbiota-host interaction in parkinson's disease: integrative multi-omics analysis of metabolic and epigenetic pathways. | AMB Express | 2026 | https://conductscience.org/library/papers/42177729 | PubMed |
| 41090700 | Association of Hormonal Status With Sarcopenia, Frailty and Outcome in Patients With Decompensated Cirrhosis. | Liver Int | 2025 | https://conductscience.org/library/papers/41090700 | PubMed |
| 40877650 | Pharmacobiochemical Analysis of the Cytoprotective Action of New 5-Androstendiol Derivatives. | Bull Exp Biol Med | 2025 | https://conductscience.org/library/papers/40877650 | PubMed |
| 40732235 | Neurosteroids Progesterone and Dehydroepiandrosterone: Molecular Mechanisms of Action in Neuroprotection and Neuroinflammation. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40732235 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39338348
GET https://conductscience.org/api/papers/v1/39338348/references?page=2